Prime Surgical, LLC
$40.5K 316 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Titan Surgical Group, Llc
Titan Surgical Group, Llc reported $40,266.21 across General Payments, Research, and Ownership to 556 physicians and teaching hospitals across 556 transactions.
- $40.3K Below-median payer
- All-tracks total
- 556 Above-median volume
- Transactions
- 556 Above-median reach
- Recipients
- +$8.6K
- General Payments vs PY2023
Titan Surgical Group, Llc reported $40,266.21 across all CMS Open Payments tracks (General + Research + Ownership) to 556 physicians and teaching hospitals in Program Year 2024 - ranking #1402 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $40,266.21, averaging $72.42 per recipient.
Titan Surgical Group, Llc's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
15/100
Total payments
F
10/100
Transaction volume
F
14/100
Physician reach
F
14/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer titan-surgical-group-llc Titan Surgical Group, Llc
$40.3K · #1402/1,925 · 0.0% industry · PY2024
- TOT $40.3K
- RANK #1402
- SHARE 0.0%
- TXN 556
- RCP 556
- CAT 2
- GEN $40.3K
- ΔGEN +$8.6K
- TOP1 3.8%
- PY 2024
Volume peers
Nearest volume peer: Prime Surgical, LLC ($40.5K)
Titan Surgical Group, Llc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Titan Surgical Group, Llc's CMS-reported General Payments increased by $8.6K (+27.2%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: TITAN SURGICAL GROUP, LLCPY2023: TITAN SURGICAL GROUP, LLCPY2024: Titan Surgical Group, Llc. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $31,667.89
- PY2024
- $40,266.21
What the Data Shows for Titan Surgical Group, Llc
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Titan Surgical Group, Llc that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
Of the 2 general-payment categories charted below, "Travel and Lodging" is the largest at $20.4K across 46 transactions, 50.6% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Travel and Lodging" leads Titan Surgical Group, Llc's 2-category general-payment breakdown at $20.4K, 50.6% of the reported total.
How Titan Surgical Group, Llc divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Travel and Lodging | $20.4K | 46 | 50.6% |
| Food and Beverage | $19.9K | 510 | 49.4% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $6,833.33 (17.0%) of $40,266.21 in this company's General Payments records across 261 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Titan Surgical Group, Llc
The five named recipients with the highest reported General Payments from this company
- 1
Taylor Kensinger
$1,545.90 across 8 reported transactions
- 2
Amar Patel
$1,378.56 across 9 reported transactions
- 3
James Halloran
$1,374.75 across 13 reported transactions
- 4
Corey Harp
$1,291.11 across 8 reported transactions
- 5
Bradley Spence
$1,243.01 across 6 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Titan Surgical Group, Llc's spend rank (#1402 of 1,925, bottom 27% by spend) and concentration rank (#1,603 of 1,838, bottom 13% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Catalyst Pharmaceuticals, Inc. : $1.1M total payments, HHI 167
- Organogenesis Inc. : $2.1M total payments, HHI 167
- Sensus Healthcare, Inc. : $4.7K total payments, HHI 165
- Neos Therapeutics, LP : $163.6K total payments, HHI 165
- PureLife, LLC : $214.1K total payments, HHI 165
- Alexion Pharmaceuticals, Inc. : $12.5M total payments, HHI 164
- Titan Surgical Group, Llc (this company) : $40.3K total payments, HHI 164
- Polaris Technology Solutions LLC : $39.0K total payments, HHI 164
- Ambu Inc. : $233.8K total payments, HHI 164
- TG Therapeutics, Inc. : $4.7M total payments, HHI 163
- Johnson & Johnson Surgical Vision, Inc. : $1.6M total payments, HHI 163
- Fortis Surgical, LLC : $45.6K total payments, HHI 163
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Titan Surgical Group, Llc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Titan Surgical Group, Llc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Titan Surgical Group, Llc.
Showing 6 of 1,924 companies with CMS-reported payment data.
GRT US Holding, Inc.
$40.0K 15 recipients
Compare payment profiles
Henry Schein One, LLC
$39.9K 213 recipients
Compare payment profiles
Inogen, Inc.
$40.6K 2,167 recipients
Compare payment profiles
Cadwell Industries, INC
$39.8K 79 recipients
Compare payment profiles
ONY Biotech Inc.
$39.6K 43 recipients
Compare payment profiles
Put this to use
Titan Surgical Group, Llc ranks #1402 of 1,925 by all-tracks total payments, led by "Travel and Lodging".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Travel and Lodging" spend across every manufacturer, not just Titan Surgical Group, Llc. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.